|
510,000 HIV tests ordered up from MedMira |
|
|
|
|
Tuesday, 22 December 2009 |
Halifax biomedical firm MedMira Inc., a developer and marketer of rapid diagnostic technology and solutions, announced Monday it has received an order for 510,000 rapid HIV tests in Africa. MedMira’s marketing and sales partner, Vitest AG of Wollerau, Switzerland, worked in the region for the past several months developing market opportunities for the Halifax company’s HIV tests.
Building on its increasing focus on Africa and other developing regions, along with the need to further develop relationships with international organizations, MedMira also received notification from the United Nations Global Marketplace that its application to become a registered supplier for the United Nations Population Fund has been accepted. MedMira and its partner Vitest are now able to participate in the population fund’s numerous procurement opportunities. "Our strategic partnership plan has reached its first major milestone. The combination of manufacturing services and sales partnerships has empowered our ability to increase our revenue expectation for the coming year," said Hermes Chan, CEO, MedMira Inc. in a news release. "We’re also very excited to become a registered supplier for the (population fund) and we are pursuing additional registrations from various organizations within the United Nations Global Marketplace in order to broaden our opportunities within the international development sector." |